“Increasing Prevalence of Congenital Illnesses”
- One prominent trend in the global newborn screening market is the increasing prevalence of congenital illnesses
- This trend is driven by the growing recognition of the importance of early detection, advancements in screening technologies, and rising healthcare awareness among parents and healthcare providers
- For instance, as the awareness around conditions such as sickle cell disease, cystic fibrosis, and phenylketonuria (PKU) grows, more governments and healthcare organizations are implementing mandatory newborn screening programs. These efforts aim to identify such disorders early and provide timely intervention
- The demand for newborn screening is expanding in developed markets, such as North America and Europe, and also in emerging markets, where rising healthcare access and infrastructure are improving early diagnostic capabilities
- As the focus on preventive healthcare continues to increase and more diseases are included in screening programs, the prevalence of congenital illnesses will likely continue to shape the growth of the newborn screening market
